These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33516794)

  • 1. Elucidation of mass transfer mechanisms in pellet formation by spheronization.
    Evers M; Mattusch A; Weis D; Garcia E; Antonyuk S; Thommes M
    Eur J Pharm Biopharm; 2021 Mar; 160():92-99. PubMed ID: 33516794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluations regarding interparticular mass transfer in spheronization.
    Koester M; Willemsen E; Krueger C; Thommes M
    Int J Pharm; 2012 Jul; 431(1-2):84-9. PubMed ID: 22546294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scale-up of the rounding process in pelletization by extrusion-spheronization.
    Evers M; Weis D; Antonyuk S; Thommes M
    Pharm Dev Technol; 2019 Oct; 24(8):1014-1020. PubMed ID: 31232624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spheronization of solid lipid extrudates: Elucidation of spheroid formation mechanism.
    Petrovick GF; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Apr; 125():148-158. PubMed ID: 29407224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the pelletization mechanism by extrusion/spheronization.
    Koester M; Thommes M
    AAPS PharmSciTech; 2010 Dec; 11(4):1549-51. PubMed ID: 21042960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process.
    Trivedi NR; Rajan MG; Johnson JR; Shukla AJ
    Crit Rev Ther Drug Carrier Syst; 2007; 24(1):1-40. PubMed ID: 17430098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between a twin-screw extruder and a rotary ring die press. Part II: influence of process variables.
    Schmidt C; Kleinebudde P
    Eur J Pharm Biopharm; 1998 Mar; 45(2):173-9. PubMed ID: 9704914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing of pellets by extrusion/spheronization using different types of equipment and process conditions.
    Bölcskei É; Regdon G; Sovány T; Ghanam D; Knop K; Kleinebudde P; Pintye-Hódi K
    Drug Dev Ind Pharm; 2014 Jun; 40(6):762-4. PubMed ID: 23596971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A data mining approach to optimize pellets manufacturing process based on a decision tree algorithm.
    Ronowicz J; Thommes M; Kleinebudde P; Krysiński J
    Eur J Pharm Sci; 2015 Jun; 73():44-8. PubMed ID: 25835791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M; Kleinebudde P
    AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spheronization of solid lipid extrudates: A novel approach on controlling critical process parameters.
    Petrovick GF; Pein M; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 May; 92():15-21. PubMed ID: 25681745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.